Rimon Newsletter February 2022
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Rimon</strong> Initiative<br />
NEWSLETTER | <strong>February</strong> <strong>2022</strong><br />
UPDATE<br />
Thank you for your interest and support of the <strong>Rimon</strong><br />
Philanthropic Investment Initiative, an innovative<br />
program from American Friends of the Hebrew<br />
University (AFHU) in partnership with the Hebrew<br />
University of Jerusalem (HU); Yissum, the university’s<br />
technology transfer company; and ASPER HUJI-<br />
Innovate, the university’s center for innovation and<br />
entrepreneurship. To date, AFHU has raised $375,000<br />
for the <strong>Rimon</strong> Philanthropic Investment Initiative. In<br />
addition, our international friends, also associated<br />
with the Hebrew University, are identifying key<br />
prospects and participants to fund the initiative. We<br />
look forward to completing the goal together so that<br />
we may formally launch the <strong>Rimon</strong> Philanthropic<br />
Investment Initiative.<br />
Thanks to your generosity, the <strong>Rimon</strong> Philanthropic<br />
Investment Initiative will target local entrepreneurship<br />
at the nexus of Israel’s innovation economy, the<br />
Hebrew University of Jerusalem, and deliver<br />
broad impact using rigorous processes of capital<br />
deployment and expert management. Your gift will<br />
translate to concrete venture creation activities<br />
resulting in impactful startups in Israel and beyond.<br />
The <strong>Rimon</strong> <strong>Newsletter</strong> is an occasion to share news,<br />
updates, and reports from our strategic partners in<br />
Israel. Through this newsletter and beyond, we will<br />
continue to share opportunities and access as they<br />
become available. Thank you again for your support,<br />
and happy reading!<br />
CONTENT<br />
<strong>Rimon</strong> Philanthropic Investment Initiative<br />
Update<br />
Yissum Technology Transfer Announces<br />
15 New Companies<br />
Yissum 2021 Portfolio<br />
Out of the Lab: Yissum Podcast<br />
ASPER-HUJI Innovate Update<br />
<strong>Rimon</strong> Spotlight - Jane and Dr. Peter<br />
Feinstein<br />
YISSUM ROUNDUP<br />
Check out what’s happening<br />
with the Hebrew University of<br />
Jerusalem in the Yissum Round<br />
Up. We are excited to share all<br />
the good news. As a tech transfer,<br />
Yissum facilitates taking cuttingedge<br />
research out of the lab<br />
and into the world, to make an<br />
impact in our daily lives. Whether<br />
it’s cultured meat you crave, or<br />
health tech, the university has it<br />
all, and soon so will you!<br />
Laura Abrams, Leadership Development Director<br />
AMERICAN FRIENDS OF THE HEBREW UNIVERSITY<br />
7777 Glades Road, Suite 401, Boca Raton, FL 33434<br />
Tel. 561.948.3344 | Fax 561.750.8292<br />
labrams@afhu.org | AFHU.ORG
<strong>Rimon</strong> Fund<br />
NEWSLETTER | <strong>February</strong> <strong>2022</strong><br />
YISSUM TECHNOLOGY TRANSFER ANNOUNCES<br />
15 NEW COMPANIES<br />
The new batch of promising startups backed by the Hebrew University of Jerusalem’s<br />
Technology Transfer includes next-generation tech spanning MRNA, genetics, delivery<br />
methods, and other pharma advancements, alongside next-gen solar technology.<br />
Tel Aviv, ISRAEL — January <strong>2022</strong> — Yissum, the Technology Transfer Company of the<br />
Hebrew University of Jerusalem, today announced its 2021 Portfolio of 15 promising new<br />
companies. Yissum established the new batch of companies based on the Hebrew University<br />
technologies, alongside a wide array of leading private investors, incubators and funds<br />
such as aMoon, Copia Investment Partners, Racah Nano Fund, Adhestick Innovations, the<br />
Kitchen and Fresh Start. These companies mark another successful year of spin-outs for the<br />
university.<br />
The growing momentum displayed by the strength of these latest startups follows a number<br />
of high-profile successes accompanied by Yissum throughout the scaling process. Among<br />
them are TriEye, FutureMeat, WILK, OrCam, BetterJuice, and Pepticom. Those companies,<br />
which in some cases reached unicorn valuation, or went public and were also joined by a<br />
record number of licensing agreements.<br />
“Yissum has long been considered Israel’s leading technology transfer company, but our<br />
recent successes along with the unprecedented level of portfolio companies, investment<br />
partners, and highly promising early-stage tech serve as a real-life testament to that fact,”<br />
said Yissum CEO Dr. Itzik Goldwaser. “While this group of startups shows promise when it<br />
comes to commercial success, they are also poised to change millions of lives and we will<br />
continue to help foster and scale these technologies in order to achieve their full potential.”<br />
The latest series of portfolio companies span from pharma and solar to food tech and 3-d<br />
printing, offering a diverse array of new products and developments that demonstrate<br />
incredible promise and commercialization potential.
<strong>Rimon</strong> Fund<br />
NEWSLETTER | <strong>February</strong> <strong>2022</strong><br />
NEW COMPANIES IN THE YISSUM PORTFOLIO<br />
RNAWay: Developed a platform for delivering siRNA to plants<br />
Immunyx Pharma: Developed technology relating to platform for neutrophil specific<br />
targeting a mode of immunotherapy<br />
Lipovac: Development of Liposome based vaccine to treat different illness indications<br />
including, but not limited to Virus infections (such as COVID -19)<br />
ExoNavis Therapeutics: Leveraging the Exosome to become a multi-drug delivery vehicle,<br />
benefiting from the unique properties of the Exosomes as a targeted drug delivery platform<br />
with potentially high synergy<br />
NexoCarp: Pickering solid dispersion and particles for the delivery of agents<br />
PSYRX: A pharmaceutical startup company that is developing tissue culture protocols for<br />
producing and isolating psilocybin and ibogaine psychedelic compounds in bioreactors for<br />
the treatment of various central nervous system diseases<br />
MyComed Super Foods: Improve skeletal quality and preventing osteoporosis using<br />
medicinal herbs and Spirulina Algae mixed in a diet<br />
Cavos: Development of new diagnostic, prognostics, and treatment options for a wide array<br />
of diseases and conditions using different genomes with unique AI-based and Machine<br />
learning tools<br />
Noga3D: Developed 3D printing materials based on epoxies<br />
I-Red Pharma: Novel treatment for diseases with new small and multi-property molecules<br />
(Superdopa and Superdopamide)<br />
SOLRA: Fully Screen-Printable Perovskite Solar Cells<br />
Sea2Cell: Cultured Fish growing fish cells in vitro<br />
EverBlue Labs: Zero-Discharge Fish Aquariums<br />
Bountica: Anti-Fungal Peptides<br />
RNABLE: Technology comprising of a novel target for the treatment of rare genetic diseases<br />
and cancer caused by nonsense mutations
<strong>Rimon</strong> Fund<br />
NEWSLETTER | <strong>February</strong> <strong>2022</strong><br />
2021 PORTFOLIO COMPANIES
<strong>Rimon</strong> Fund<br />
NEWSLETTER | <strong>February</strong> <strong>2022</strong><br />
OUT OF THE LAB<br />
We are pleased to share the first episode of the new podcast series, Out of the Lab by<br />
Yissum, the technology transfer of the Hebrew University of Jerusalem.<br />
The first episode features Professor Yossi Tam, Head of the Obesity & Metabolism<br />
Laboratory and Director of the Multidisciplinary Center for Cannabinoid Research, as<br />
he discusses his childhood dreams, Israel as the Cannabis Nation, and his work with the<br />
father of cannabis, Professor Raphael Mechoulam.<br />
Out of the Lab is available at the following providers:<br />
Spotify: https://fal.cn/3lbmO<br />
Google Podcast: https://fal.cn/3lbmR<br />
Apple Podcasts: https://fal.cn/3lbmS<br />
ASPER-HUJI INNOVATE UPDATE<br />
Click here for November - December 2021 Highlights!<br />
JOIN OUR NETWORK<br />
<strong>Rimon</strong> Philanthropic Investment<br />
Initiative donation page.<br />
Share the <strong>Rimon</strong> Philanthropic<br />
Investment Initiative with your network.<br />
Visit the <strong>Rimon</strong> website.
<strong>Rimon</strong> Fund<br />
NEWSLETTER | <strong>February</strong> <strong>2022</strong><br />
RIMON SPOTLIGHT - JANE AND DR. PETER FEINSTEIN<br />
Our interest in the <strong>Rimon</strong> Initiative was sparked by its focus on startup companies.<br />
We are involved in evaluating and investing in many early stage companies as<br />
Angel/early round investors. So many startups conceived and built in Israel have<br />
substantially improved the lives of millions of people around the world. Through the<br />
<strong>Rimon</strong> initiative, we are delighted to boost young companies from Hebrew University<br />
so that their innovations can also change the world. Our involvement has exposed<br />
us to value, ingenuity and entrepreneurship that is incredible. Participation in the<br />
<strong>Rimon</strong> Initiative allows us to further enable this great work at the Hebrew University.<br />
Jane and Dr. Peter Feinstein<br />
Laura Abrams, Leadership Development Director<br />
AMERICAN FRIENDS OF THE HEBREW UNIVERSITY<br />
7777 Glades Road, Suite 401, Boca Raton, FL 33434<br />
Tel. 561.948.3344 | Fax 561.750.8292<br />
labrams@afhu.org | AFHU.ORG
Change language